<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="63911">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02085837</url>
  </required_header>
  <id_info>
    <org_study_id>13-033</org_study_id>
    <nct_id>NCT02085837</nct_id>
  </id_info>
  <brief_title>Healthy Transitions in Late Stage Kidney Disease</brief_title>
  <official_title>An Open Label Randomized Controlled Study to Compare the Impact of Patient Centered Nursing Services in Addition to a Nephrologist's Usual Patient Care With Usual Nephrologist's Care in Late Stage Chronic Kidney Disease Patients.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>North Shore Long Island Jewish Health System</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>North Shore Long Island Jewish Health System</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Improve health and outcome for people with late stage chronic kidney disease by providing
      patient centered nursing services in addition to a Nephrologist's routine patient care.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">April 2016</completion_date>
  <primary_completion_date type="Anticipated">April 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research</study_design>
  <primary_outcome>
    <measure>Hospitalization rate</measure>
    <time_frame>18 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Reduction in hospitalization rate in intervention group as compare to control group.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improve arterio-venous (AV) fistula rate</measure>
    <time_frame>18 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>A comprehensive stepwise program to ensure AV fistula placement in all appropriate patients.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Home dialysis</measure>
    <time_frame>18 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Increase choice of home dialysis as modality of treatment</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Chronic Kidney Disease</condition>
  <arm_group>
    <arm_group_label>Healthy Transitions Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Additional nursing services will be provided to this group in addition to a usual care by Nephrologist.
Daily weight measurement and monitoring
Medication review
Universal dietary education
Focused advanced directive program
Countdown to fistula program</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Usual care by nephrologist. No additional nursing support services will be provide to this group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Education</intervention_name>
    <description>Additional education will be provided by nurses to improve communication and reduce fragmentation of care.</description>
    <arm_group_label>Healthy Transitions Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Daily weight measurement and monitoring</intervention_name>
    <description>Monitor weight to avoid problems related to hypervolemia.</description>
    <arm_group_label>Healthy Transitions Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Universal Dietary education</intervention_name>
    <description>To improve diet and health</description>
    <arm_group_label>Healthy Transitions Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Medication review</intervention_name>
    <description>Medication will be reviewed by nurses to detect any discrepancies to reduce medication error.</description>
    <arm_group_label>Healthy Transitions Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Focused advanced directive program</intervention_name>
    <description>Education will be provided to increase awareness and encourage patients to have advanced directive.</description>
    <arm_group_label>Healthy Transitions Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Countdown to fistula program</intervention_name>
    <description>To reduce the number of patients starting dialysis with catheter in place, comprehensive stepwise intervention will be provided by nurses to ensure arterio-venous (AV) fistula placement in all appropriate patients, with coordinated follow up and failure recovery processes.</description>
    <arm_group_label>Healthy Transitions Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Stage 4-5 Chronic Kidney Disease (CKD), defined as estimated glomerular filtration
             rate (eGFR) between 0-30 ml/minute

          -  18 years of age or older

        Exclusion Criteria:

          -  Cognitive impairment that is clinically apparent
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steven Fishbane, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>North Shore Long Island Jewish Health System</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Steven Fishbane, MD</last_name>
    <phone>516-465-8200</phone>
    <email>sfishbane@nshs.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Vipulbhai Sakhiya</last_name>
    <phone>516-465-8841</phone>
    <email>vsakhiya@nshs.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Division of Kidney diseases and Hypertension</name>
      <address>
        <city>Great Neck</city>
        <state>New York</state>
        <zip>11021</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steven Fishbane, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Vipulbhai Sakhiya</last_name>
    </contact_backup>
    <investigator>
      <last_name>Steven Fishbane, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 7, 2014</lastchanged_date>
  <firstreceived_date>March 7, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
